.novartis
Is .novartis a real TLD? Who’s applying to run it?
.novartis is not contested. One application for it is on ICANN’s Reveal Day list, as of 7 October 2026. It is Novartis AG.
A private corporate namespace for one company; no one else can buy an address, so there is no market beyond its own use.
the applicant company itself and its internal teams, agencies and regional units, for controlled corporate, product and campaign addresses under a single-registrant namespace
The 2012 applications making the most similar bet. Chosen by AI from every string in that round, without being told what happened to any of them.
Same bet exactly: a coined, meaningless-outside-the-company corporate name for a top-ten global pharmaceutical group, where the string's only value is being the single worldwide identity of one regulated manufacturer and nobody else can plausibly claim it.
Also a globally recognized big-pharma corporate mark applied for as the firm's own namespace, carrying the same requirement that a highly regulated, trust-sensitive company control every label under its name rather than sell or share any of it.
Same category of bet — an invented pharma holding-company name claimed as a private corporate namespace — but the string was a brand-new coinage with no public equity yet, so it was buying recognition for an unknown name rather than fencing an established one.
What a .novartis domain is
.novartis is not a TLD yet. It is a string on our record of the ICANN 2026 new gTLD round, filed under Brand. One application for it is on ICANN’s Reveal Day list.
Is the .novartis domain extension real yet?
.novartis is not yet a domain extension you can register: nothing resolves under it, and no registrar sells names in it. It is a string applicants have put forward in the ICANN 2026 new gTLD round, the process that decides whether it becomes one.
When can you buy a .novartis domain?
You can’t yet. ICANN publishes every applied-for string on Reveal Day, 7 October 2026 at 18:00 UTC. A .novartis name can only be registered after that, once the string is delegated and its registry opens. Last round's closest parallel to .novartis was .sanofi, delegated on 24 July 2015.
Is .novartis a real TLD?
Not yet. .novartis is not in the DNS root, so nothing resolves under it. It’s here because .novartis is on ICANN’s Reveal Day list of applied-for strings. Every entry on this page links to its source.
- Novartis AG · first recordedICANN
- Band chosen: 10-29 (vanity/narrow). The record shows a single confirmed application of ICANN type 'brand' by Novartis AG, which under the brand-TLD model means a closed, single-registrant namespace: no third-party registrations, no resale, no aftermarket. The only buyer is the applicant, so the score rests entirely on end-use utility to that one organization. By analogy (flagged as analogy), brand TLDs from the earlier round split into a minority that moved parts of their corporate web presence onto the brand string and a majority that were delegated and left largely dormant or used for redirects; which path a given brand takes is not predictable from the string alone. It is not in the 30-49 band because that band presumes registrations at volume or on price and at least a thin aftermarket, none of which can exist in a closed namespace. It is not in the 1-9 band because a well-resourced single registrant can realistically run its namespace as a primary identity for corporate, product and secure-communication addresses, which is a genuine if captive use rather than no use at all. Main market uncertainty: whether the operator actually migrates primary web and email identity onto the string over the next 5 years or treats it as a defensive, redirect-only holding; the former would justify the upper part of this band, the latter the lower part.